Restasis (Allergan Inc)
Restasis (Allergan Inc) Brand names, Restasis (Allergan Inc) Analogs
Restasis (Allergan Inc) Brand Names Mixture
- No information avaliable
Restasis (Allergan Inc) Chemical_Formula
C62H111N11O12
Restasis (Allergan Inc) RX_link
http://www.rxlist.com/cgi/generic3/restasis.htm
Restasis (Allergan Inc) fda sheet
Restasis (Allergan Inc) msds (material safety sheet)
Restasis (Allergan Inc) Synthesis Reference
No information avaliable
Restasis (Allergan Inc) Molecular Weight
1202.61
Restasis (Allergan Inc) Melting Point
No information avaliable
Restasis (Allergan Inc) H2O Solubility
No information avaliable
Restasis (Allergan Inc) State
Liquid
Restasis (Allergan Inc) LogP
4.293
Restasis (Allergan Inc) Dosage Forms
Capsule (liquid-filled); Capsule (liquid-filled for emulsion); Solution (oral); Solution (IV infusion)
Restasis (Allergan Inc) Indication
For treatment of transplant rejection, rheumatoid arthritis, severe psoriasis
Restasis (Allergan Inc) Pharmacology
Used in immunosuppression for prophylactic treatment of organ transplants, cyclosporine exerts specific and reversible inhibition of immunocompetent lymphocytes in the G0-or G1-phase of the cell cycle. T-lymphocytes are preferentially inhibited. The T1-helper cell is the main target, although the T1-suppressor cell may also be suppressed. Sandimmune (cyclosporine) also inhibits lymphokine production and release including interleukin-2.
Restasis (Allergan Inc) Absorption
No information avaliable
Restasis (Allergan Inc) side effects and Toxicity
No information avaliable
Restasis (Allergan Inc) Patient Information
BIOD00003.html
Restasis (Allergan Inc) Organisms Affected
Humans and other mammals
